FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

70961008: Neomycin sulfate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
117867011 Neomycin sulfate en Synonym Active Entire term case insensitive SNOMED CT core module
501730016 Neomycin sulphate en Synonym Active Entire term case insensitive SNOMED CT core module
811074015 Neomycin sulfate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neomycin sulfate Is a Product containing neomycin false Inferred relationship Existential restriction modifier
Neomycin sulfate Is a Bactericide false Inferred relationship Existential restriction modifier
Neomycin sulfate Is a Neomycin false Inferred relationship Existential restriction modifier
Neomycin sulfate Is a Substance with aminoglycoside structure and antibacterial mechanism of action true Inferred relationship Existential restriction modifier
Neomycin sulfate Is modification of Neomycin true Inferred relationship Existential restriction modifier
Neomycin sulfate Has disposition Antibacterial true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neomycin sulfate [systemic] Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 500 milligram/1 each conventional release oral tablet Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neomycin sulfate [eye] Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 milliliter conventional release eye drops Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neomycin sulfate 0.5% single-use eye drops Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neomycin sulfate [ear] Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neomycin sulfate [skin] Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 25 milligram/1 milliliter conventional release oral solution Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neo-tabs 500mg tablet Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Mycifradin 125mg/5mL oral solution Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neo-fradin 125mg/5mL oral solution Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Chlorhexidine hydrochloride+neomycin sulfate Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unit/3.5mg/10000unit ophthalmic ointment Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Colistin sulfate + hydrocortisone acetate + neomycin sulfate 3mg/10mg/3.3mg solution Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unit ointment Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Dexamethasone + neomycin sulfate 1mg/3.5mg ointment Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/3.5mg/10000 unit suspension Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/10000unt suspension Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/1000unt solution Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Colistin sulfate + hydrocortisone acetate + neomycin sulfate Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Hydrocortisone acetate+neomycin sulfate Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing dexamethasone and neomycin sulfate and polymyxin B sulfate Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing dexamethasone sodium phosphate and neomycin sulfate Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neomycin sulfate allergy Causative agent False Neomycin sulfate Inferred relationship Existential restriction modifier
Chlorhexidine hydrochloride and neomycin sulfate adverse reaction Causative agent False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Allergy to chlorhexidine hydrochloride and neomycin sulfate Causative agent False Neomycin sulfate Inferred relationship Existential restriction modifier
Clobetasol propionate+neomycin sulfate+Nystatin Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing clobetasone butyrate and neomycin sulfate Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Neomycin sulfate allergy Causative agent False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 500 milligram/1 each conventional release oral tablet Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 500 milligram/1 each conventional release oral tablet Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Neomycin sulfate 0.5% conventional release eye drops Has active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 500 milligram/1 each conventional release oral tablet Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 25 milligram/1 milliliter conventional release oral solution Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 25 milligram/1 milliliter conventional release oral solution Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment Has basis of strength substance False Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment Has precise active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has basis of strength substance False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has precise active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Neomycin sulfate 0.5% conventional release eye drops Has precise active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Neomycin sulfate 0.5% conventional release eye drops Has basis of strength substance False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has precise active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has basis of strength substance False Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has basis of strength substance False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has precise active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter conventional release eye drops Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter conventional release eye drops Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops Has basis of strength substance False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops Has precise active ingredient False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Allergy to chlorhexidine hydrochloride and neomycin sulfate Causative agent False Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release ear solution (clinical drug) Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye drops (clinical drug) Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has basis of strength substance True Neomycin sulfate Inferred relationship Existential restriction modifier 2
Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug) Has precise active ingredient True Neomycin sulfate Inferred relationship Existential restriction modifier 3

Page 1 of 6 Next End

This concept is not in any reference sets

Back to Start